Hepatic Growth Hormone Resistance in young Women with Type 1 Diabetes: Comparison with controls and effects of oral and transdermal estrogen administration.
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Estrogen (Primary) ; Estrogen (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms EsTiD
- 10 May 2016 Status changed from recruiting to completed.
- 30 Oct 2014 Accrual to date is 58% according to United Kingdom Clinical Research Network record.
- 02 Oct 2014 Planned End Date changed from 31 Jul 2014 to 30 Jun 2015 as reported by United Kingdom Clinical Research Network record.